Photo from Tom Powles/X
May 26, 2024, 11:35
Bladder cancer highlights for ASCO24 by Tom Powles
Tom Powles, Director of Barts Cancer Center, shared on X/Twitter:
“Bladder cancer highlights for ASCO24. Practice informing data. .
PK and QOL data for EV/EVP are helpful. Highlighting responders for gem/cis/nivo in M1 disease informs us about the winners.
ctDNA/ctDNA clearance in M1 disease for chemo vs pembro looks new. Neoadjuvant SG plus IO is important.”
Source: Tom Powles/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 18, 2024, 22:22
Nov 18, 2024, 22:02
Nov 18, 2024, 21:55
Nov 18, 2024, 20:54
Nov 18, 2024, 18:36
Nov 18, 2024, 18:32